The 17th ISDE Virtual World Congress for Esophageal Diseases was a successful event all because of you, our attendees, faculty, and the committees. Thank you for supporting #ISDE2021. And if you have not yet registered – you can still do so and watch all sessions on-demand! Posters and presentations will be available for streaming for 6 months, using your registration log-in.

Finally, don't forget to save the date for next year's Congress: September 26-28, 2022 in Tokyo, Japan.

We are pleased to announce the newly elected Officers and Executive Committee of the 2021 - 2022 ISDE Board of Directors. See who they are on the Board of Directors page.

It is with great pleasure to present a Distinguished Membership of the International Society for Diseases of the Esophagus (ISDE) to André Duranceau and Glyn Jamieson.

The criteria for this award is “being a distinguished person who has achieved prominence in the field of the esophagus and related diseases, and who has contributed to its advancement”.

Both professors have contributed in an extraordinary way to the ISDE, and the field of esophageal disease. Thank you! Check out some of their notable achievements.

It's almost the end of the year which means it's time to renew your ISDE membership. New memberships or renewals submitted from now until the end of the year are carried over to January 1, 2022. If you aren't an ISDE member, don't miss out.

During this webinar an international panel of speakers discussed the importance of registries and audits in esophagogastric cancer surgery, and shared updates from around the world including set-up, results and the effect registries have had on national or regional outcomes. Panelists also discussed the way research has been incorporated into registries. Watch the recordings here.

Look through the abstracts submitted to the 17th ISDE World Congress for Esophageal Diseases. See the full table of contents.

Myotomy in sigmoid megaesophagus: is it applicable? A systematic review and meta-analysis 

Achalasia is a rare esophageal primary motor dysfunction with no cure. The aim of the achalasia therapy is to palliate the symptoms, mainly dysphagia. Its treatment usually focuses on inferior esophageal sphincter disruption, leading to facilitated food transit to the stomach. It can be done by surgical myotomy or endoscopic procedures, such as cardia dilatation or peroral endoscopic myotomy (POEM). Read the full article.

The great challenge in the treatment of reflux disease in persistently symptomatic patients using ppi is to find studies with a large sample and a long following that point out which factors may contribute to the difficult management of disease control.

In this study, a large number of variables related to the characteristics of the patients, the presence of anatomical changes, the functional condition of the esophagus and the degree of severity of the reflux disease were evaluated.

Their results increasingly help to understand which disease markers in these patients who have persistent symptoms may be relevant to better control disease progression. Read the full article.

Presentation, Treatment, and Prognosis of Esophageal Carcinoma in a Nationwide Comparison of Sweden and the Netherlands 

Intestinal Metaplasia in the Esophageal Remnant Is Rare After Ivor Lewis Esophagectomy 

The Circular Stapled Esophagogastric Anastomosis in Esophagectomy: No Differences in Anastomotic Insufficiency and Stricture Rates Between the 25 mm and 28 mm Circular Stapler 

Improving Outcome of Superior Mediastinal Lymph Node Dissection During Esophagectomy 

Incidence and Risk Factors for Diaphragmatic Herniation Following Esophagectomy for Cancer 

Visit the ISDE Literature Updates Online for more.